• Octagam 10% approved for adult dermatomyositis

    1 month ago - By Healio

    The FDA has approved intravenous immunoglobulin Octagam 10% for the treatment of adult dermatomyositis, Octapharma USA announced in a press release.
    A rare idiopathic autoimmune disease, dermatomyositis affects approximately 10 out of every million people in the U.S. and causes skin rashes, chronic muscle inflammation and progressive muscle weakness.
    Octagam 10% was effective in 78.7% of patients with dermatomyositis during an initial 16-week double-blind, placebo-controlled phase of the ProDERM clinical trial. During a 24-week open-label extension phase of the trial, patients in the placebo
    Read more ...

     

  • FDA approves Twyneo cream for acne vulgaris

    FDA approves Twyneo cream for acne vulgaris

    1 month ago - By Healio

    Twyneo cream, a fixed-dose combination of tretinoin and benzoyl peroxide, has been approved by the FDA for the treatment of acne vulgaris, Sol-Gel Technologies announced in a press release.
    The cream, which uses the company's patented technology to entrap the retinoid tretinoin and benzoyl peroxide in silica-based microcapsules, was approved for adults and children 9 years and older.
    “Based on the clinical data observed, we believe that Twyneo has the potential to change the treatment landscape for the tens of millions of patients suffering from acne vulgaris,” Alon Seri-Levy,
    Read more ...